Cristina C. Clement, Ph.D. - Publications

Affiliations: 
2006 City University of New York, New York, NY, United States 
Area:
Biochemistry

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Babinska A, Clement CC, Li Y, Wzorek J, Przygodzki T, Talar M, Braun M, Swiatkowska M, Ehrlich YH, Kornecki E, Watala C, Salifu MO. data: treatment with the F11R/JAM-A peptide 4D decreases mortality and reduces the generation of atherosclerotic plaques in ApoE-deficient mice. Data in Brief. 30: 105516. PMID 32395574 DOI: 10.1016/J.Dib.2020.105516  0.395
2019 Babinska A, Clement CC, Przygodzki T, Talar M, Li Y, Braun M, Wzorek J, Swiatkowska M, Ehrlich YH, Kornecki E, Watala C, Salifu MO. A peptide antagonist of F11R/JAM-A reduces plaque formation and prolongs survival in an animal model of atherosclerosis. Atherosclerosis. 284: 92-101. PMID 30877938 DOI: 10.1016/J.Atherosclerosis.2019.02.014  0.348
2018 Cheng SY, Vargas A, Lee JY, Clement CC, Champeil E. Involvement of Akt in Mitomycin C and Its Analog Triggered Cytotoxicity in MCF-7 and K562 cancer cells. Chemical Biology & Drug Design. PMID 30091208 DOI: 10.1111/Cbdd.13374  0.392
2018 Clement CC, Gonzalez J, Babinska A, Ewul EL, Timpo E, Salifu MO, Monika D. Development of a label‒free nanolc/ms/ms assay for monitoring the changes in the proteomic landscape of thrombin‒activated human platelets Moj Proteomics & Bioinformatics. 7. DOI: 10.15406/Mojpb.2018.07.00242  0.554
2014 Babinska A, Clement CC, Swiatkowska M, Szymanski J, Shon A, Ehrlich YH, Kornecki E, Salifu MO. Development of new antiatherosclerotic and antithrombotic drugs utilizing F11 receptor (F11R/JAM-A) peptides. Biopolymers. 101: 322-34. PMID 24801754 DOI: 10.1002/Bip.22503  0.565
2012 Figueiredo AC, Clement CC, Zakia S, Gingold J, Philipp M, Pereira PJ. Rational design and characterization of D-Phe-Pro-D-Arg-derived direct thrombin inhibitors. Plos One. 7: e34354. PMID 22457833 DOI: 10.1371/Journal.Pone.0034354  0.531
2011 Carvalho Figueiredo A, Clement CC, Philipp M, Barbosa Pereira PJ. Crystallization and preliminary crystallographic characterization of three peptidic inhibitors in complex with α-thrombin. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 67: 54-8. PMID 21206024 DOI: 10.1107/S1744309110043472  0.658
2011 Pereira PJB, Figueiredo AC, Macedo-Ribeiro S, Philipp M, Clement CC. Structural characterization ofD-Phe-Pro-D-Arg-derived thrombin inhibitors Acta Crystallographica Section a Foundations of Crystallography. 67: C311-C312. DOI: 10.1107/S010876731109218X  0.524
2009 Clement CC, Babinska A, Kornecki E, Philipp M. Isothermal titration calorimetry and inhibition of platelets aggregation by [D-Phe/(transcinnamoyl)-Pro-D-Arg-P1'-CONH2] peptides inhibitors of thrombin. Advances in Experimental Medicine and Biology. 611: 579-80. PMID 19400322 DOI: 10.1007/978-0-387-73657-0_255  0.659
2001 Subramaniam G, Paz MM, Suresh Kumar G, Das A, Palom Y, Clement CC, Patel DJ, Tomasz M. Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite 2,7-diaminomitosene and DNA. Basis of sequence selectivity. Biochemistry. 40: 10473-84. PMID 11523988 DOI: 10.1021/Bi015147X  0.311
Show low-probability matches.